Z p ; M V w { t b * Z C { - Japan Patent Office ... p t f [ c z T m z V w Y p s b p t ^ s M \ q E q b { G F x z H w X w O t S M o o M g ~ Z w s ` h w p K { w O p x H H t V w x z g x Z w h

Embed Size (px)

Text of Z p ; M V w { t b * Z C { - Japan Patent Office ... p t f [ c z T m z V w Y p s b p t ^ s M \ q ...

  • - 1

  • - 2

  • - 3

  • - 4

  • i

    OECD

    2006 2 OECD

    NIH

    NIH NIH

    EC 1998

    2006 5 2007 3

    2007 5 2007

  • ii

    OECD(Organisation for Economic

    Co-operation and Development )

    EU(European Union;

    OECDEU

    ii

  • iii

    iiiiv

    TRIPS 30

    30

    69 1

    60 5 (b) 11 (b)

    613 5(b) 28 (1)(b)

    2007 6 22 9 (1)b

  • iv

    2005 4 28 28 (1)(b)

    (on)

    (with)

    2007 6 22

    9 (1)

    1984 FDA

    2005

  • v

    NIHNational Institutes of HealthNIH

    1999

    NIH

    OECD 2002 2006 2

    OECD

    OECD

    OECD

    2006 5 23

  • vi

    2007 3 1

    OECD

    OECD

    PIPLA 2007 10 SC4SM

  • vii

    iPS

    1980

    1988 1980

    20

    21

    Myriad

    OECD 2003

    OECD

    OECD

    OECD

  • viii

    OECD OECD

    OECD

  • ( OECD)

  • . ...................................... 1

    .................................................... 1

    .......................................... 3

    ...................................... 3

    ........................................ 4

    ................................................ 4

    .................................... 5

    .......................................... 5

    ...................................................... 6

    .............................................. 6

    .............................................. 6

    ........................................ 8

    .............................................. 8

    .................................................. 8

    ................................................ 8

    ...................................... 10

    .............................................. 16

    ................................................ 16

    ...................................... 19

    .................................................. 25

    ................................................ 25

    ............................................ 28

    ...................................... 36

    EU(European Union; .......................... 38

    ................................................ 38

    ...................................... 39

    .................................................. 44

  • ................................................ 44

    ............................................ 46

    ...................................... 48

    ................................................ 60

    ................................................ 60

    ............................................ 62

    ...................................... 64

    .............................................. 71

    ................................................ 71

    ............................................ 73

    ...................................... 76

    .............................................. 78

    ................................................ 78

    ............................................ 80

    ...................................... 85

    ................................................ 87

    ................................................ 87

    ............................................ 89

    ...................................... 93

    .......................................... 94

    ............................ 94

    .......... 94

    .................................... 94

    ............................................ 96

    ........................ 97

    ................................ 98

    ................................................................ 99

  • 3

    61

    75

    113

    123

    165

  • - 1 -

    .

    OECD

    1 2006 2 OECD

    NIH

    NIH 2

    EC 1998

    3 2006 5 2007

    3

    4

    1 http://www.oecd.org/dataoecd/39/38/36198812.pdf2 http://ott.od.nih.gov/NewPages/64FR72090.pdf3 http://www8.cao.go.jp/cstp/output/iken060523_2.pdf4 http://www8.cao.go.jp/cstp/output/iken070301.pdf

  • - 2 -

    2007 5 20075

    5 http://www.kantei.go.jp/jp/singi/titeki2/kettei/070531keikaku.pdf

  • - 3 -

    OECD TRIPS

    2.1

    OECD(Organisation for Economic Co-operation and

    Development)

    TRIPS Agreement on Trade-Related Aspects of

  • - 4 -

    Intellectual Property Rights;

    EU(European Union;

    2.1

    2.1

    Prof.Joshua D. Sarnoff Wahington College of LawAmerican Univ.

    Prof.Jeremy Phillips IP Consultant of OlswangEditor of Oxford Journal of Intellectual Property Law & Practice

    Dr. Prinz zu Waldeck und Pyrmont Program Director, Munich Intellectual Property Law CenterMember of the Research Staff, Max Planck Institute for Intellectual Property, Competition and Tax Law

    Mr. Alain Gallochat Former Adviser to the governmentConsultant

    Dr. Lucas Bu"hler Swiss Federal Institute of Intellectual Property

    Prof. Dr. Geertrui Van Overwalle Katholieke Universiteit Leuven

    Ms. Christina Sampogna Administrator Biotechnology Division

  • - 5 -

    OECD

    2.1

  • - 6 -

    2.1 2.2

    2.2 2.1

    2.2

    Item Object Description( analysis includes evaluation )

    1 Settled law suites and its regalanalysis

    * Settled law suites * Analysis of law suites including judgment,process of argument, its effect on the followinglaw suites, movement of the government,research activity etc.

    * Theoretical analysis

    * Summary of information in academic paperand journals etc

    2 Law suites pending in court andincidents and troubles

    * Unsettled law suites Analysis of law suites, incidents and troublesincluding the forecast of judgment, process ofargument, its effect on the following law suites,movement of the government, research activityetc.

    * Unsettled troubles andincidents ( outside court )

    * Summary of information in academic paperand journals etc

    3 The trend of law and regulation * The trend of discussion andactivities amonggovernmental, political,bureaucratic, business, andacademic circles and generalpublic

    * Analysis

    * Summary of information in academic journalsetc

    4 4. The discussion upon law andregulation,and its social back ground

    * The discussion upon law andregulation, and its social background among governmental,political, bureaucratic,business, and academiccircles

    * Analysis

    * The discussion upon law andregulation, and its social background and of general public

    * Summary of information listed in right columns

  • - 7 -

    5 Altering process and background ofthe altering law (ex. Belgium)

    * The history of of altering,including political and socialprocess

    * Analysis

    * The action and reaction ofpolitical circle

    * The action and reaction ofacademia

    * The action and reaction ofbusiness circle

    * The social background ofaltering law

    * Summary of information in publication

    6 The process and background tostart, the process to alter the law(ex. UK, Swiss)

    * The history of of altering,including political and socialprocess

    * Analysis

    * The action and reaction ofpolitical, academic andbusiness people

    * The social background ofaltering law

    * Summary of information in academic journalsetc

    7 The guideline to protect and useresearch tool patents

    * Guidelines of government andprivate sector

    * Analysis

    * Summary of information in report fromgovernment, business and academic sector.

    8 The status quo of using theguideline

    * Working mechanism inacademic and businessresearch.

    * Analysis

    * The opinion of academic andbusiness circle

    * Summary of information in academic journalsetc

    9 Other information( technologicalfield, bibliographic item, price tolicense etc )

    * Major items not includedabove items

    * Analysis

    * Summary of information in academic journalsetc

    10 OECD guideline * Working mechanism of theguideline

    * Analysis

    Status quo of using * Summary of information in academic journalsetc

    11 NIH guideline * Working mechanism of theguideline

    * Analysis

    * Status quo of using * Summary of information in academic journalsetc

  • - 8 -

    2.1

    69 1

    2004 11

  • - 9 -

    2006 5 23

    2007 3 1

    OECD NIH

  • - 10 -

    2006.5.23

    http://www8.cao.go.jp/cstp/output/iken060523_2.pdf

    1.(2)

    2.(1)

    3.

  • - 11 -

    2007.3.1

    http://www8.cao.go.jp/cstp/output/iken070301.pdf

    1.

  • - 12 -

    2.

    3.

    4.

  • - 13 -

    5.

  • - 14 -

    2004.11

    http://www.jpo.go.jp/shiryou/toushin/shingikai/pdf/strategy_wg_prob/00.pdf

    691

    69

    2

    691

    691

  • - 15 -

    691

    691

    69 1

    TRIPS

  • - 16 -

    OECD

    30 OECD 2006

    OECD (GUIDELINES FOR THE LICENSING OF GENETIC

    INVENTIONS)

    OECD

    OECD

    6

    7

    OECD

    TRIPS

    6 OECD JBA 1.http://www.jba.or.jp/top/top%20data/oecdguideline060323.pdf

    7 7.

  • - 17 -

    TRIPS Agreement on Trade-Related Aspects of Intellectual

    Property Rights; 30

    31

Recommended

View more >